1. Home
  2. CPSH vs FLNA Comparison

CPSH vs FLNA Comparison

Compare CPSH & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPS Technologies Corp.

CPSH

CPS Technologies Corp.

HOLD

Current Price

$5.92

Market Cap

68.9M

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$1.32

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPSH
FLNA
Founded
1984
1998
Country
United States
United States
Employees
N/A
20
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
61.8M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
CPSH
FLNA
Price
$5.92
$1.32
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
486.5K
382.6K
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
113.64
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.41
N/A
Revenue Next Year
$20.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.11
$1.16
52 Week High
$6.85
$2.03

Technical Indicators

Market Signals
Indicator
CPSH
FLNA
Relative Strength Index (RSI) 63.11 41.11
Support Level $3.20 $1.16
Resistance Level $6.85 $1.80
Average True Range (ATR) 0.63 0.08
MACD 0.10 0.01
Stochastic Oscillator 79.08 48.39

Price Performance

Historical Comparison
CPSH
FLNA

About CPSH CPS Technologies Corp.

CPS Technologies Corp designs, manufactures, and sells high-performance material solutions for customers across various markets, including transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company develops and applies proprietary expertise in metal matrix composites (MMCs), which are engineered materials combining metals and ceramics to achieve enhanced performance properties. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers. The majority of the company's revenue is derived from the sale of its products in the United States of America.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: